missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Equine IL-4 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
POA
Specifications
| Molecular Weight (g/mol) | 12.6 kDa |
|---|---|
| Name | IL-4 |
| Quantity | 20μg |
| Source | E. coli-derived equine IL-4 protein Lys26-Cys137 |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
Description
The Recombinant Equine IL-4 Protein is derived from E. coli. The Recombinant Equine IL-4 Protein has been validated for the following applications: Bioactivity.Specifications
| 12.6 kDa | |
| 20μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| IL-4 | |
| E. coli-derived equine IL-4 protein Lys26-Cys137 | |
| B cell growth factor 1, BCDF, B-cell stimulatory factor 1, BCGF1, BCGF-1, binetrakin, BSF1, BSF-1, IL4, IL-4B_cell stimulatory factor 1, IL4E12, interleukin 4, interleukin-4, Lymphocyte stimulatory factor 1, MGC79402, Pitrakinra | |
| Recombinant |